Request for Covid-19 Impact Assessment of this Report
According to 99Strategy, the Global Patient Derived Xenograft Models Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Patient Derived Xenograft Models market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Crown Bioscience Inc. (US)
WuXi AppTec (China)
Champions Oncology, Inc. (US)
The Jackson Laboratory (US)
ONCODESIGN (France)
Charles River Laboratories International, Inc. (US)
EPO Berlin-Buch GmBH (Germany)
Shanghai LIDE Biotech Co., Ltd (China)
Xentech (France)
Horizon Discovery Group PLC (UK)
Urolead (France)
Explora BioLabs (US)
Key Product Type
Mice Models
Rat Models
Market by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutions
Main Aspects covered in the Report
Overview of the Patient Derived Xenograft Models market including production, consumption, status & forecast and market growth
2016-2020 historical data and 2021-2026 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
Impact of Coronavirus on the Industry
1 Industrial Chain Overview
1.1 Patient Derived Xenograft Models Industry
1.1.1 Overview
Figure Patient Derived Xenograft Models Picture List
1.1.2 Characteristics of Patient Derived Xenograft Models
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Mice Models
1.3.2 Rat Models
1.4 End-Use List
1.4.1 Demand in Pharmaceutical & Biotechnology Companies
1.4.2 Demand in Contract Research Organizations
1.4.3 Demand in Academic & Research Institutions
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2016-2026
Figure Global Market Size and Forecast with Growth Rate, 2016-2026
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026
Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026
Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026
Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2016-2020, in Volume
Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2016-2020, in Volume
Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD
Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2016-2020, in Volume
Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD
Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume
Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
3.2 Manufacturers List
3.2.1 Crown Bioscience Inc. (US) Overview
Table Crown Bioscience Inc. (US) Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of Crown Bioscience Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 WuXi AppTec (China) Overview
Table WuXi AppTec (China) Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of WuXi AppTec (China) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Champions Oncology, Inc. (US) Overview
Table Champions Oncology, Inc. (US) Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of Champions Oncology, Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 The Jackson Laboratory (US) Overview
Table The Jackson Laboratory (US) Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of The Jackson Laboratory (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 ONCODESIGN (France) Overview
Table ONCODESIGN (France) Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of ONCODESIGN (France) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Charles River Laboratories International, Inc. (US) Overview
Table Charles River Laboratories International, Inc. (US) Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of Charles River Laboratories International, Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 EPO Berlin-Buch GmBH (Germany) Overview
Table EPO Berlin-Buch GmBH (Germany) Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of EPO Berlin-Buch GmBH (Germany) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Shanghai LIDE Biotech Co., Ltd (China) Overview
Table Shanghai LIDE Biotech Co., Ltd (China) Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of Shanghai LIDE Biotech Co., Ltd (China) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Xentech (France) Overview
Table Xentech (France) Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of Xentech (France) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Horizon Discovery Group PLC (UK) Overview
Table Horizon Discovery Group PLC (UK) Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of Horizon Discovery Group PLC (UK) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Urolead (France) Overview
Table Urolead (France) Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of Urolead (France) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Explora BioLabs (US) Overview
Table Explora BioLabs (US) Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Patient Derived Xenograft Models Business Operation of Explora BioLabs (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2016-2020, in Volume
Figure Global Market Size and Growth Rate, 2016-2020, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
Figure Global Production Volume Share by Manufacturers in 2020, in Volume
Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
Figure Global Production Amount Share by Manufacturers in 2020, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Mice Models
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Mice Models , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Mice Models , 2016-2020, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Rat Models
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Rat Models, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Rat Models, 2016-2020, in Volume
5.2.2.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume
6.2 Segment Subdivision
6.2.1 Market in Pharmaceutical & Biotechnology Companies
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Pharmaceutical & Biotechnology Companies , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Pharmaceutical & Biotechnology Companies , 2016-2020, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Contract Research Organizations
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Contract Research Organizations , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Contract Research Organizations , 2016-2020, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Academic & Research Institutions
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Academic & Research Institutions, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Academic & Research Institutions, 2016-2020, in Volume
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2021-2026, in Million USD
Table Global Market Forecast by Region Segment 2021-2026, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2021-2026, in Million USD
Table Global Market Volume by Product Type Segment 2021-2026, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2021-2026, in Million USD
Table Global Market Volume by End-Use Segment 2021-2026, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Patient Derived Xenograft Models Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion
Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Crown Bioscience Inc. (US) Overview List
Table Patient Derived Xenograft Models Business Operation of Crown Bioscience Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table WuXi AppTec (China) Overview List
Table Patient Derived Xenograft Models Business Operation of WuXi AppTec (China) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Champions Oncology, Inc. (US) Overview List
Table Patient Derived Xenograft Models Business Operation of Champions Oncology, Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table The Jackson Laboratory (US) Overview List
Table Patient Derived Xenograft Models Business Operation of The Jackson Laboratory (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table ONCODESIGN (France) Overview List
Table Patient Derived Xenograft Models Business Operation of ONCODESIGN (France) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Charles River Laboratories International, Inc. (US) Overview List
Table Patient Derived Xenograft Models Business Operation of Charles River Laboratories International, Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table EPO Berlin-Buch GmBH (Germany) Overview List
Table Patient Derived Xenograft Models Business Operation of EPO Berlin-Buch GmBH (Germany) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Shanghai LIDE Biotech Co., Ltd (China) Overview List
Table Patient Derived Xenograft Models Business Operation of Shanghai LIDE Biotech Co., Ltd (China) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Xentech (France) Overview List
Table Patient Derived Xenograft Models Business Operation of Xentech (France) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Horizon Discovery Group PLC (UK) Overview List
Table Patient Derived Xenograft Models Business Operation of Horizon Discovery Group PLC (UK) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Urolead (France) Overview List
Table Patient Derived Xenograft Models Business Operation of Urolead (France) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Explora BioLabs (US) Overview List
Table Patient Derived Xenograft Models Business Operation of Explora BioLabs (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume
Table Global Market Forecast by Region Segment 2021-2026, in Million USD
Table Global Market Forecast by Region Segment 2021-2026, in Volume
Table Global Market Amount by Product Type Segment 2021-2026, in Million USD
Table Global Market Volume by Product Type Segment 2021-2026, in Volume
Table Global Market Amount by End-Use Segment 2021-2026, in Million USD
Table Global Market Volume by End-Use Segment 2021-2026, in Volume
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...